Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Syndax Pharmaceuticals (SNDX) Operating Expenses: 2015-2024

Historic Operating Expenses for Syndax Pharmaceuticals (SNDX) over the last 10 years, with Dec 2024 value amounting to $363.4 million.

  • Syndax Pharmaceuticals' Operating Expenses rose 38.77% to $20.2 million in Q4 2020 from the same period last year, while for Dec 2020 it was $72.9 million, marking a year-over-year increase of 23.51%. This contributed to the annual value of $363.4 million for FY2024, which is 58.01% up from last year.
  • Syndax Pharmaceuticals' Operating Expenses amounted to $363.4 million in FY2024, which was up 58.01% from $230.0 million recorded in FY2023.
  • Syndax Pharmaceuticals' Operating Expenses' 5-year high stood at $363.4 million during FY2024, with a 5-year trough of $72.9 million in FY2020.
  • Moreover, its 3-year median value for Operating Expenses was $230.0 million (2023), whereas its average is $248.4 million.
  • Data for Syndax Pharmaceuticals' Operating Expenses shows a peak YoY spiked of 58.01% (in 2024) over the last 5 years.
  • Syndax Pharmaceuticals' Operating Expenses (Yearly) stood at $72.9 million in 2020, then soared by 55.59% to $113.5 million in 2021, then spiked by 33.72% to $151.8 million in 2022, then spiked by 51.53% to $230.0 million in 2023, then spiked by 58.01% to $363.4 million in 2024.